Sally Beauty Hldgs SEC Filings

Sally Beauty Holdings, Inc. filed a notice that a shareholder plans to sell shares under Rule 144. The filing covers a proposed sale of 5,900 shares of common stock through UBS Financial Services Inc. on or about 12/11/2025, with an indicated aggregate market value of 92,925. The company had 97,497,664 shares of common stock outstanding at the time referenced in the notice.

The shares to be sold were acquired on 11/15/2024 through restricted stock vesting from Sally Beauty Holdings, Inc., with payment described as cash. The person signing the notice represents that they are not aware of any undisclosed material adverse information about the company’s current or prospective operations.

Sally Beauty Holdings, Inc. is asking stockholders to vote at its virtual annual meeting on January 22, 2026 on three items: electing ten directors to one-year terms, approving an advisory vote on executive compensation, and ratifying KPMG LLP as auditor for fiscal 2026.

For fiscal 2025, SBH reported net sales of $3.7 billion, a 0.4% decrease from the prior year, with global e-commerce sales of $397 million, or 11% of total net sales. GAAP and adjusted operating earnings were both $328 million, with an 8.9% operating margin, and the company repurchased approximately 5 million shares for $53 million.

The board highlights corporate governance, diversity and sustainability, noting that 60% of director nominees are women and nine of ten nominees are independent. The company emphasizes initiatives in culture and belonging, human capital development, environmental sustainability, responsible sourcing, data protection and cybersecurity, and philanthropic efforts focused on combating domestic violence and supporting employees facing hardship.

Sally Beauty Holdings executive insider activity shows a stock sale by a senior officer. On 12/01/2025, an officer of Sally Beauty Holdings, Inc. with the title SVP, CLO and CHRO reported selling 15,000 shares of common stock in an open market transaction coded as a sale. The weighted average sale price was $16.2724, with individual trades executed in a price range from $16.245 to $16.315. After this transaction, the reporting person beneficially owned 57,585 shares of Sally Beauty common stock directly. The filing notes that multiple same-way sale transactions were aggregated into a single line within a one-dollar price range, and detailed trade-by-trade pricing is available upon request.

A holder of Sally Beauty Holdings common stock filed a notice to sell 15,000 shares under Rule 144 through UBS Financial Services Inc., with an approximate sale date of December 1, 2025 on the NYSE.

The filing lists an aggregate market value of $244,050 for these shares and notes that 97,497,664 common shares are outstanding. The seller acquired the stock mainly through restricted stock awards and restricted stock unit vesting between September 2021 and November 2022, with cash listed as the form of payment at vesting.

Sally Beauty Holdings (SBH)November 15, 2025, the officer acquired 16,782 shares of common stock at $0 through the vesting and conversion of restricted stock units (RSUs). On the same date, 6,272 shares were disposed of at $14.18 per share, typically reflecting shares withheld to cover taxes. After these transactions, the officer directly owned 27,195 shares of SBH common stock.

The filing also details multiple RSU and performance stock unit (PSU) conversions on November 15, 2025, each on a one-for-one basis into common stock, with some RSU awards continuing to vest annually through November 15, 2027.

Sally Beauty Holdings (SBH)November 15, 2025. The executive acquired 48,138 shares of common stock at an exercise price of $0 through the vesting and conversion of restricted stock units (RSUs), then disposed of 17,984 shares at $14.18, likely to cover taxes. Following these transactions, the officer directly owned 72,585 shares of SBH common stock. Several RSU and performance stock unit (PSU) awards were exercised at $0, with some awards now fully settled and others continuing to vest annually through November 15, 2027 on a one-for-one basis into common stock.

Sally Beauty Holdings (SBH)November 15, 2025, several tranches of restricted stock units (RSUs) and performance stock units (PSUs) converted into common stock on a one-for-one basis at an exercise price of $0, including blocks of 12,607, 17,667, 10,383, 12,132, 4,304, 3,847, and 5,067 shares as they vested. The filing also shows a disposition of 24,657 shares of common stock at $14.18 per share with transaction code "F," indicating shares withheld or sold to cover taxes. Following the reported transactions, the reporting person directly holds 128,976 shares of SBH common stock.

Sally Beauty Holdings (SBH) reported insider equity activity for its SVP & President, Sally Beauty, on November 15, 2025. The executive acquired 66,007 shares of common stock at $0 per share through the conversion of previously granted restricted stock units (RSUs), which convert into common stock on a one-for-one basis. On the same date, 24,657 shares were disposed of at $14.18 per share, designated with transaction code “F,” indicating shares withheld to cover tax obligations on the vesting. After these transactions, the executive directly owned 115,484 shares of common stock. Multiple RSU awards were exercised at an exercise price of $0, with some awards continuing to vest in equal installments on November 15, 2025, 2026, and 2027, while others fully vested by November 15, 2025.

Sally Beauty Holdings (SBH) senior vice president and chief financial officer reported equity award activity involving company stock. On 11/15/2025, the officer acquired 77,496 shares of common stock at an exercise price of $0, reflecting the vesting and conversion of restricted stock units into shares. On the same date, 29,087 shares of common stock were disposed of at $14.18 per share in a transaction coded "F," typically used for shares withheld or sold to cover taxes. After these transactions, the officer directly beneficially owned 138,145 shares of SBH common stock.

The derivative table shows multiple restricted stock unit awards converting into common stock on a one-for-one basis, including tranches of 12,607, 19,630, 13,151, 15,366, 5,451, 4,873, and 6,418 shares tied to vesting schedules through November 2027, with some performance stock units noted as earned and vested.